Ernesto Maddaloni Selected Research

Ernesto Maddaloni Research Topics

Disease

14	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2022 - 01/2013
13	Type 2 Diabetes Mellitus (MODY) 10/2022 - 06/2012
10	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2017
5	COVID-19 01/2022 - 01/2020
4	Insulin Resistance 10/2022 - 06/2012
4	Diabetes Mellitus 01/2022 - 01/2015
4	Atherosclerosis 01/2022 - 05/2016
4	Hyperglycemia 01/2018 - 06/2012
3	Heart Failure 05/2022 - 01/2019
3	Latent Autoimmune Diabetes in Adults 01/2022 - 01/2015
3	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Hemorrhage 01/2022 - 01/2021
2	Obesity 01/2022 - 01/2021
2	Weight Loss (Weight Reduction) 01/2022 - 03/2014
2	Chronic Renal Insufficiency 01/2022 - 11/2020
2	Overweight 01/2021 - 03/2014
2	Inflammation (Inflammations) 03/2020 - 01/2018
2	Renal Insufficiency (Renal Failure) 01/2020 - 09/2015
2	Myocardial Infarction 01/2019 - 01/2015
2	Hyperinsulinism (Hyperinsulinemia) 01/2018 - 05/2016
1	Disease Progression 10/2022
1	Diabetes Complications 10/2022
1	Left Ventricular Dysfunction 05/2022
1	Arteritis 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2022
1	Coronary Disease (Coronary Heart Disease) 03/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2020
1	Pneumonia (Pneumonitis) 03/2020
1	Infections 03/2020
1	Blindness (Hysterical Blindness) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2019
1	Bone Fractures (Bone Fracture) 01/2019
1	Stroke (Strokes) 01/2019
1	Dyslipidemias (Dyslipidemia) 10/2018
1	Atherosclerotic Plaque (Atheroma) 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018

Drug/Important Bio-Agent (IBA)

13	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2014
11	Insulin (Novolin)FDA Link 10/2022 - 06/2012
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2019
4	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2022 - 01/2019
4	AutoantibodiesIBA 01/2020 - 03/2012
4	OsteocalcinIBA 01/2020 - 01/2013
3	Apolipoproteins E (ApoE)IBA 01/2022 - 05/2016
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2019
3	LipidsIBA 11/2020 - 01/2018
2	AntibodiesIBA 01/2022 - 01/2019
2	HDL CholesterolIBA 01/2022 - 01/2021
2	Endothelin Receptors (Endothelin Receptor)IBA 01/2022 - 05/2016
2	CreatinineIBA 01/2022 - 04/2015
2	Interleukin-6 (Interleukin 6)IBA 03/2020 - 01/2018
2	CytokinesIBA 03/2020 - 01/2018
2	Vitamin D FDA LinkGeneric 01/2018 - 04/2015
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2018 - 01/2015
2	Calcitriol (Calcijex)FDA LinkGeneric 09/2015 - 01/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2015 - 06/2012
1	C-PeptideIBA 10/2022
1	AlbuminsIBA 01/2022
1	arginine methyl esterIBA 01/2022
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2022
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2022
1	MineralsIBA 01/2022
1	Insulin ReceptorIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	EpitopesIBA 01/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 12/2021
1	VaccinesIBA 09/2021
1	Glucagon (Glukagon)FDA Link 03/2021
1	SodiumIBA 03/2021
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2021
1	Ranolazine FDA Link 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 11/2020
1	Monoclonal AntibodiesIBA 03/2020
1	RNA (Ribonucleic Acid)IBA 03/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 03/2020
1	Janus Kinase InhibitorsIBA 03/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Thioctic Acid (Lipoic Acid)IBA 11/2019
1	NAD (NADH)IBA 11/2019
1	LDL CholesterolIBA 10/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2018
1	Ezetimibe (Zetia)FDA Link 10/2018
1	PhlorhizinIBA 01/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018
1	ApolipoproteinsIBA 01/2018

Therapy/Procedure

13	Therapeutics 10/2022 - 06/2012
6	Glycemic Control 07/2020 - 06/2012
2	Percutaneous Coronary Intervention 01/2022 - 01/2015
2	Immunotherapy 12/2021 - 05/2015
2	Secondary Prevention 01/2021 - 01/2019
1	Investigational Therapies (Experimental Therapy) 12/2021
1	Artificial Respiration (Mechanical Ventilation) 10/2021
1	Light Coagulation 01/2020